Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Moderna to Cut 10% of Global Workforce | Contract Pharma

What are you searching for?

Sign in
Breaking News

Moderna to Cut 10% of Global Workforce

To layoff 5,000 employees by the end of the year; aims to reduce operating expenses by approximately $1.5 billion by 2027.

Image: Moderna

Moderna is reducing its workforce by approximately 10% globally, or 5,000 employees, by the end of the year.

Earlier this year, the company announced plans to reduce its annual operating expenses by approximately $1.5 billion by 2027. The company has been scaling down R&D as respiratory trials conclude, renegotiating supplier agreements, and reducing manufacturing costs. 

CEO Stephane Bancel, said, “Today, reshaping our operating structure and aligning our cost structure to the realities of our business are essential to remain focused and financially disciplined, while continuing to invest in our science on the path to 2027.”

Moderna has had lower than expected uptake of its respiratory syncytial virus vaccine, newer mRNA vaccines, including its experimental COVID-flu combination vaccine.

The European commission recently approved an updated COVID-19 vaccine targeting SARS-CoV-2 Variant LP.8.1.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics